News | August 06, 2021
Strides to acquire US manufacturing facility of Endo for $24 mn
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
He will be stationed at the company HQ in Bengaluru, India
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
The data should be submitted by August 12th 2021
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
AstraZeneca, Sinopharm and Moderna were part of the study
Arrow is the marketing partner in US
_logo_256_384.jpg){kind=logo}
It supports sequencing-based COVID 19 surveillance in India
Subscribe To Our Newsletter & Stay Updated
